21st Century Cures Act Addresses Obstacles to Stopping Antibiotic Resistance
June 7th 2018A lack of coordination among regulating bodies, pharma manufacturers, standard development organizations, and laboratory testing device companies has muddied efforts to stop antibiotic resistance; the 21st Century Cures Act aims to fix that.
FDA Approves Biosimilar to Neulasta for the Prevention of Infection During Cancer Treatment
June 5th 2018Fulphila is the first biosimilar to Neulasta to decrease the chance of infection in patients with non-myeloid cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.
Studies Reveal New Treatment Options for Nontuberculous Mycobacterial Lung Disease
June 4th 2018Although the incidence of nontuberculous mycobacterial (NTM) lung disease is increasing, and current treatment options are limited, certain NTM patients may find a potential treatment option in video-assisted thoracoscopic surgery.
Recommended Gonorrhea Treatment Regimen Not Received by 20% of Patients in the US
May 30th 2018Although most health care providers are adhering to the recommended regimen, the US Centers for Disease Control and Prevention reports that about 20% of patients with uncomplicated gonorrhea are not receiving the recommended dual regimen designed to ward off resistance.